Investing.com -- The Cigna Group (NYSE: CI) reported third-quarter earnings that exceeded analyst expectations, with shares edging up 0.3% following the announcement.

The global health company posted adjusted earnings of $7.83 per share for the third quarter, surpassing the analyst consensus of $7.64. Revenue climbed 10% YoY to $69.7 billion, above the $67.61 billion analysts had projected. The company reaffirmed its full-year 2025 outlook for adjusted income from operations of at least $29.60 per share, slightly below the consensus estimate of $29.63.

"Our strong quarterly results reflect the breadth of our businesses and focused execution on our growth strategy, even in a dynamic environment," said David M. Cordani, chairman and CEO of The Cigna Group.

The company’s Evernorth Health Services segment was a key growth driver, with adjusted revenues increasing 15% compared to the same period last year. Pharmacy Benefit Services revenue jumped 18%, while Specialty and Care Services revenue rose 10%, reflecting strong specialty volume growth and increased adoption of biosimilars.

Cigna Healthcare saw its adjusted income from operations decrease 12% compared to the third quarter of 2024, primarily due to a higher medical care ratio, which rose to 84.8% from 82.8% a year earlier.

Total pharmacy customers increased 4% from December 2024 to 122.5 million, while total medical customers decreased 6% to 18.1 million, primarily reflecting the impact of the HCSC transaction completed in March 2025.

The company also announced a new rebate-free pharmacy benefit model designed to lower costs and improve transparency for customers.